NRX Pharmaceuticals Inc (NRXP)
3.02
+0.03
(+1.00%)
USD |
NASDAQ |
Apr 23, 12:44
NRX Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2023 | 7.119 |
| March 29, 2023 | 7.244 |
| March 28, 2023 | 7.002 |
| March 27, 2023 | 7.024 |
| March 24, 2023 | 7.050 |
| March 23, 2023 | 6.764 |
| March 22, 2023 | 6.954 |
| March 21, 2023 | 6.568 |
| March 20, 2023 | 6.761 |
| March 17, 2023 | 6.854 |
| March 16, 2023 | 6.638 |
| March 15, 2023 | 6.568 |
| March 14, 2023 | 6.703 |
| March 13, 2023 | 6.404 |
| March 10, 2023 | 6.472 |
| March 09, 2023 | 6.857 |
| March 08, 2023 | 6.578 |
| March 07, 2023 | 6.578 |
| March 06, 2023 | 7.103 |
| March 03, 2023 | 7.309 |
| March 02, 2023 | 7.035 |
| March 01, 2023 | 8.497 |
| February 28, 2023 | 9.319 |
| February 27, 2023 | 9.228 |
| February 24, 2023 | 9.136 |
| Date | Value |
|---|---|
| February 23, 2023 | 9.502 |
| February 22, 2023 | 9.959 |
| February 21, 2023 | 9.959 |
| February 17, 2023 | 10.14 |
| February 16, 2023 | 9.867 |
| February 15, 2023 | 9.776 |
| February 14, 2023 | 9.959 |
| February 13, 2023 | 10.42 |
| February 10, 2023 | 10.23 |
| February 09, 2023 | 10.32 |
| February 08, 2023 | 10.05 |
| February 07, 2023 | 11.24 |
| February 06, 2023 | 11.42 |
| February 03, 2023 | 11.42 |
| February 02, 2023 | 11.42 |
| February 01, 2023 | 10.78 |
| January 31, 2023 | 10.69 |
| January 30, 2023 | 11.15 |
| January 27, 2023 | 11.24 |
| January 26, 2023 | 11.42 |
| January 25, 2023 | 11.69 |
| January 24, 2023 | 11.69 |
| January 23, 2023 | 11.51 |
| January 20, 2023 | 11.88 |
| January 19, 2023 | 11.51 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.068
Minimum
Jun 16 2022
72.80
Maximum
Oct 14 2021
12.46
Average
5.885
Median
Dec 06 2022
Price to Book Value Benchmarks
| Achieve Life Sciences Inc | -- |
| Dare Bioscience Inc | -- |
| Zevra Therapeutics Inc | 3.092 |
| Kodiak Sciences Inc | 0.6836 |
| INmune Bio Inc | 4.750 |
Price to Book Value Related Metrics
| Price | 3.02 |
| Earnings Yield | -132.5% |
| Market Cap | 28.90M |